Page last updated: 2024-08-24

celgosivir and Hepatitis C, Chronic

celgosivir has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Durantel, D	1

Reviews

1 review(s) available for celgosivir and Hepatitis C, Chronic

Article	Year
Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:8 Topics: alpha-Glucosidases; Animals; Antiviral Agents; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Indolizines; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin	2009

Article

Year

Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.

Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:8

Topics: alpha-Glucosidases; Animals; Antiviral Agents; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Indolizines; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin

2009